guerard: ophthalmology important to novartis (ois@asrs 2016)
Published 8 years ago • 260 plays • Length 9:10Download video MP4
Download video MP3
Similar videos
-
29:00
how do strategics view retina opportunities? (ois@asrs 2016)
-
7:59
welcome to ois@asrs 2016
-
7:45
opthea: targeting a more complete blockade of vegf (ois@asrs 2016)
-
22:20
retina experts serve up a combination platter at ois@asrs (ois@asrs 2016)
-
8:04
aerpio therapeutics: focus on tie2 activation (ois@asrs 2016)
-
6:56
ocular therapeutix: intravitreal depot technology for retinal drug delivery (ois@asrs 2016)
-
10:15
novartis’ guerard updates on moves into presbyopia, dry eye
-
29:49
ois podcast ep #403: revolutionizing corneal health
-
11:27
justice of an eye for an eye
-
3:33
visa classification of graves’ orbitopathy
-
14:58
catch up on ois@aao’s year in review (ois@aao 2016)
-
7:53
trukera medical - adam szaronos, ceo
-
6:58
oxurion - public company showcase at ophthalmology innovation summit @ asrs 2019
-
5:59
regeneron: pursuing combination therapies with pdgfr-beta and ang2 (ois@asrs 2016)
-
6:38
retina 2019 and beyond - neurotech pharmaceuticals at ophthalmology innovation summit @ aao 2019
-
25:50
steinert honored for his career of innovation
-
6:17
keranova - innovation showcase at ophthalmology innovation summit @ ascrs 2019
-
7:15
eyenovia - innovation showcase at ophthalmology innovation summit @ aao 2019
-
6:04
novaliq gmbh - innovation showcase at ophthalmology innovation summit @ ascrs 2019
-
7:44
retina 2019 and beyond - ocutrx vision technologies at ophthalmology innovation summit @ aao 2019
-
7:25
digital ophthalmology sector overview - ois@aao 2015